1. Home
  2. ASTL vs MYGN Comparison

ASTL vs MYGN Comparison

Compare ASTL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

HOLD

Current Price

$4.38

Market Cap

467.0M

Sector

Industrials

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.14

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTL
MYGN
Founded
1902
1991
Country
Canada
United States
Employees
N/A
2700
Industry
Steel/Iron Ore
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.0M
481.6M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ASTL
MYGN
Price
$4.38
$5.14
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$8.06
AVG Volume (30 Days)
1.4M
1.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
N/A
$7.19
Revenue Next Year
N/A
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$3.02
$3.76
52 Week High
$7.25
$11.44

Technical Indicators

Market Signals
Indicator
ASTL
MYGN
Relative Strength Index (RSI) 45.21 51.59
Support Level $4.14 $4.82
Resistance Level $4.64 $5.67
Average True Range (ATR) 0.28 0.39
MACD -0.04 0.13
Stochastic Oscillator 12.58 64.60

Price Performance

Historical Comparison
ASTL
MYGN

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: